VHCP Management II’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

VHCP Management II’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$25.2M	Sell	462,903 -250,000	-35%	-$12.4M	6.64%	4
2019 Q3	$29.7M	Sell	712,903 -250,000	-26%	-$10.6M	11.33%	2
2019 Q2	$42.2M	Sell	962,903 -175,172	-15%	-$9.87M	13.29%	3
2019 Q1	$58.6M	Hold	1,138,075	–	–	17.14%	2
2018 Q4	$42.1M	Sell	1,138,075 -277,316	-20%	-$10M	18.07%	1
2018 Q3	$53.1M	Hold	1,415,391	–	–	14.19%	2
2018 Q2	$55.9M	Buy	1,415,391 +25,000	+2%	+$793K	16.74%	2
2018 Q1	$35.8M	Sell	1,390,391 -328,214	-19%	-$9.81M	8.64%	4
2017 Q4	$46.4M	Buy	1,718,605 +54,305	+3%	+$1.5M	11.11%	2
2017 Q3	$60.8M	Hold	1,664,300	–	–	16.81%	2
2017 Q2	$37.9M	Buy	+1,664,300	New	+$38.3M	15.15%	2

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VHCP Management II's BHVN Position: Q4 2019 in Review

VHCP Management II reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 35% in Q4 2019, selling an estimated $12.4M and leaving 462,903 shares worth $25.2M. The position accounts for 6.64% of the portfolio, ranked #4.

VHCP Management II first reported a position in BHVN in Q2 2017 and has held it in 11 quarters since. The position peaked at $60.8M in Q3 2017. 188 funds tracked by Wall St. Rank hold BHVN as of Q4 2019.

VHCP Management II held 462,903 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $25.2M as of Q4 2019.
VHCP Management II sold 250,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2019, an estimated $12.4M.
Biohaven Pharmaceutical Holding Company Ltd. made up 6.64% of VHCP Management II's portfolio in Q4 2019, its #4 holding.
VHCP Management II first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and has held it in 11 quarters since.
VHCP Management II's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $60.8M in Q3 2017.
188 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.